$6.1 Bn Vaccine Contract Manufacturing Market by Vaccine Type, Workflow, Application, and Region 2024-2032
05 sept. 2024 10h53 HE
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing Market Report by Vaccine Type, Workflow, Application, and Region 2024-2032" report has been added to ...
Vaccine Adjuvants Strategic Research Report 2024
05 sept. 2024 04h05 HE
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
Meningococcal VaccinesGlobal Strategic Business Report to 2030 Featuring Baxter International, Bio-Med, GlaxoSmithKline, Pfizer, Sanofi, and Serum Institute of India Among Others
05 sept. 2024 04h04 HE
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
04 sept. 2024 09h15 HE
|
FN Media Group LLC
PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for...
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
04 sept. 2024 08h30 HE
|
FN Media Group LLC
PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The emergence of SARS-CoV-2, which triggered the COVID-19 pandemic with overall is widely regarded as the...
Pneumococcal Vaccine Market Research Report 2024
03 sept. 2024 11h24 HE
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccine Market Report by Vaccine Type, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
02 sept. 2024 18h40 HE
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030
30 août 2024 04h05 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
Tetanus Toxoid Vaccine Strategic Research Report 2024: Rising Awareness of Vaccine-Preventable Diseases Drives Demand - Global Market Forecast to 2030
29 août 2024 11h00 HE
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Tetanus Toxoid Vaccine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Tetanus...
Therapeutic Vaccines Strategic Research Report 2024
29 août 2024 10h51 HE
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Therapeutic...